Alterity Therapeutics Ltd.ASX: ATH

ATH completes enrolment in ATH434-201 Phase 2 clinical trial

Nov 8, 2023 at 3:48 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment